Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 6Progesterone Resistance 1Periodontitis 1Menstruation Disturbances 1Insulin Resistance 1Hyperandrogenism 1Hirsutism 1Gingivitis 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Amenorrhea 1

Interventions

Metformin 3drospirenone and ethinyl estradiol combination 2Caloric Restriction 2cinnulin PF 1Yoga 1Ultrasonography 1Sugars 1Population Groups 1Inositol 1Hematologic Tests 1Glucose Tolerance Test 1Folic Acid 1Ethinyl Estradiol 1Doxycycline 1Diet 1Cyproterone acetate, ethinyl estradiol drug combination 1Control Groups 1Contraceptives, Oral 1Acupuncture Therapy 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Menstruation Disturbances × Cyproterone acetate, ethinyl estradiol drug combination × Clear all
NCT02027337 2014-11-21

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Tyumen State Medical Academy

Phase 4 Unknown
200 enrolled

Menstruation Disturbances, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡